APOE4 and Genetic Testing: What a Result Can and Cannot Tell You

Consumer genetic testing has made APOE status available to people who did not seek genetic counselling and may not have expected the result. Understanding what it means is worth doing before testing, not after.

What APOE is

The APOE gene codes for apolipoprotein E, involved in lipid transport. It has three common variants: e2, e3 and e4. Everyone carries two copies, one from each parent.

The e3 variant is the most common. The e4 variant has been associated with increased risk of late-onset Alzheimer's disease, with the association stronger for people carrying two copies. The e2 variant has been associated with reduced risk.

Deterministic genes are different

A small number of rare mutations — in genes including PSEN1, PSEN2 and APP — are associated with early-onset familial Alzheimer's disease and behave much more deterministically. These are uncommon and account for a small fraction of cases, typically with onset before sixty-five and a striking family history across generations.

Testing for these is a different matter from APOE testing and is handled through clinical genetics services with counselling, for good reason.

What a result actually gives you

An APOE4 result shifts your estimated lifetime risk relative to the population average. It does not tell you whether you will develop the disease, when, or how severely. Risk estimates also vary by sex, ancestry and other factors, and figures quoted in one population do not transfer straightforwardly to another.

There is no established intervention specific to APOE4 carriers that differs from what is recommended generally — cardiovascular risk management, physical activity, sleep, hearing, not smoking. The main practical implication for most carriers is a stronger reason to do what is already recommended.

Before testing, consider

• What would you do differently? If the answer is nothing, the information may carry cost without benefit.
• Psychological impact. Studies of disclosure have found that many people cope well, but distress does occur, and anxiety about memory has its own cognitive costs.
• Family implications. Your result carries information about relatives who did not choose to know.
• Insurance and legal context. Protections vary by country and by type of insurance. In the United States, the Genetic Information Nondiscrimination Act addresses health insurance and employment but does not cover life, disability or long-term care insurance. This is worth understanding before testing rather than after.
• Genetic counselling. Available through health services and worth using, particularly where there is a significant family history.

Family history without testing

Having a parent or sibling with dementia is associated with somewhat elevated risk, but the majority of cases are not attributable to a single inherited variant. Shared environment and lifestyle contribute as well.

A strong pattern — multiple affected relatives, particularly with early onset — is a reason to discuss clinical genetic assessment with a doctor.

If you already have a result

If a consumer test has reported e4 status and it is causing distress, discussing it with a doctor or genetic counsellor is reasonable. The result does not tell you what will happen to you, and the modifiable risk factors remain modifiable regardless of genotype. That is not reassurance for its own sake — it is what the evidence supports.